Chromatin modification, leukaemia and implications for therapy.

Chromatin modification, leukaemia and implications for therapy.

Item
http://www.wikidata.org/entity/Q34786248
Panobinostat as part of induction and maintenance for elderly patients with newly diagnosed acute myeloid leukemia: phase Ib/II panobidara studyMyelodysplastic syndrome and histone deacetylase inhibitors: "to be or not to be acetylated"?Linking the epigenetic 'language' of covalent histone modifications to cancer.Genes.Novel therapeutic agents for cutaneous T-Cell lymphoma.Epigenetic targets in hematological malignancies: combination therapies with HDACis and demethylating agents.Histone deacetylase inhibitors in lymphoma and solid malignancies.Histone deacetylase inhibitors decrease NHEJ both by acetylation of repair factors and trapping of PARP1 at DNA double-strand breaks in chromatin.Emerging role of epigenetic therapies in cutaneous T-cell  lymphomas.Epigenetic aberrations during oncogenesis.New drug therapies in peripheral T-cell lymphoma.CTCF regulates growth and erythroid differentiation of human myeloid leukemia cells.The synergy of panobinostat plus doxorubicin in acute myeloid leukemia suggests a role for HDAC inhibitors in the control of DNA repair.The DAC system and associations with acute leukemias and myelodysplastic syndromes.Acetylation- and Methylation-Related Epigenetic Proteins in the Context of Their Targets.Pilot study of combination transcriptional modulation therapy with sodium phenylbutyrate and 5-azacytidine in patients with acute myeloid leukemia or myelodysplastic syndrome.
P2860

Chromatin modification, leukaemia and implications for therapy.

Item
http://www.wikidata.org/entity/Q34786248
description
2002 nî lūn-bûn
@nan
2002 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Chromatin modification, leukaemia and implications for therapy.
@ast
Chromatin modification, leukaemia and implications for therapy.
@en
Chromatin modification, leukaemia and implications for therapy.
@nl
type
label
Chromatin modification, leukaemia and implications for therapy.
@ast
Chromatin modification, leukaemia and implications for therapy.
@en
Chromatin modification, leukaemia and implications for therapy.
@nl
prefLabel
Chromatin modification, leukaemia and implications for therapy.
@ast
Chromatin modification, leukaemia and implications for therapy.
@en
Chromatin modification, leukaemia and implications for therapy.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P698
P921
P356
P1433
P1476
Chromatin modification, leukaemia and implications for therapy
@en
P2093
P2860
P304
P31
P356
10.1046/J.1365-2141.2002.03586.X
P407
P433
P478
P50
P577
P698
P921